Narrowing the gaps between what we know and what we do in psychiatry

Journal of Clinical Psychiatry

Volumn 76, Issue 10, 2015, Pages 1366-1372

  Rush, A John ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL DECISION MAKING; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DATA MINING; EVIDENCE BASED MEDICINE; HEALTH CARE SYSTEM; HUMAN; MEDICAL PRACTICE; MEDICAL RESEARCH; MONITORING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHIATRY; RISK BENEFIT ANALYSIS; SCREENING; DECISION SUPPORT SYSTEM; FINANCIAL MANAGEMENT; MENTAL DISORDERS; PROCEDURES;

BIOMEDICAL RESEARCH; DECISION SUPPORT TECHNIQUES; HUMANS; MENTAL DISORDERS; PSYCHIATRY; RESEARCH SUPPORT AS TOPIC;

EID: 84945385256     PISSN: 01606689     EISSN: 15552101     Source Type: Journal    
DOI: 10.4088/JCP.15ac10309     Document Type: Conference Paper

References (40)

1. Ideographic versus nomothetic approaches. In: Marshall G. A Dictionary of Sociology. 2nd ed. New York, NY: Oxford University Press; 1998.
2. Wisniewski SR, Rush AJ, Nierenberg AA, et al. Can phase III trial results of antidepressant medications be generalized to clinical practice? a STAR∗D report. Am J Psychiatry. 2009;166(5):599-607.
3. Trivedi MH, Rush AJ, Wisniewski SR, et al; STAR∗D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR∗D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40.
4. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR∗D report. Am J Psychiatry. 2006;163(11):1905-1917.
5. Olsen LA, Aisner D, McGinnis JM; IOM Roundtable on Evidence-Based Medicine. The Learning Healthcare System: Workshop Summary. Washington, DC: National Academies Press; 2007.
6. Ostergaard SD, Bech P, Trivedi MH, et al. Brief, unidimensional melancholia rating scales are highly sensitive to the effect of citalopram and may have biological validity: implications for the Research Domain Criteria (RDoC). J Affect Disord. 2014;163:18-24.
7. Selby JV, Lipstein SH. PCORI at 3 years- progress, lessons, and plans. N Engl J Med. 2014;370(7):592-595.
8. Kapur S, Phillips AG, Insel TR. Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol Psychiatry. 2012;17(12):1174-1179.
9. Schneeweiss S. Learning from big health care data. N Engl J Med. 2014;370(23):2161-2163.
10. Mintz J, Mintz LI, Arruda MJ, et al. Treatments of depression and the functional capacity to work: corrections. Arch Gen Psychiatry. 1993;50(3):241.
11. Trivedi MH, Fava M, Wisniewski SR, et al; STAR∗D Study Team. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006;354(12):1243-1252.
12. Bech P, Fava M, Trivedi MH, et al. Outcomes on the pharmacopsychometric triangle in bupropion-SR vs buspirone augmentation of citalopram in the STAR∗D trial. Acta Psychiatr Scand. 2012;125(4):342-348.
13. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290(12):1624-1632.
14. Fiore LD, Brophy M, Ferguson RE, et al. A pointof- care clinical trial comparing insulin administered using a sliding scale versus a weight-based regimen. Clin Trials. 2011;8(2):183-195.
15. Chow SC, Chang M. Adaptive Design Methods in Clinical Trials. 2nd ed. Boca Raton, FL: CRC Press; 2011.
16. Murphy SA, Oslin DW, Rush AJ, et al; MCATS. Methodological challenges in constructing effective treatment sequences for chronic psychiatric disorders [published online November 8, 2006]. Neuropsychopharmacology. 2007;32(2):257-262.
17. Thorpe KE, Zwarenstein M, Oxman AD, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol. 2009;62(5):464-475.
18. McGinn TG, Guyatt GH, Wyer PC, et al; Evidence-Based Medicine Working Group. Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. JAMA. 2000;284(1):79-84.
19. Stiell IG, Wells GA. Methodologic standards for the development of clinical decision rules in emergency medicine. Ann Emerg Med. 1999;33(4):437-447.
20. Laupacis A, Sekar N, Stiell IG. Clinical prediction rules: a review and suggested modifications of methodological standards. JAMA. 1997;277(6):488-494.
21. Wasson JH, Sox HC, Neff RK, et al. Clinical prediction rules: applications and methodological standards. N Engl J Med. 1985;313(13):793-799.
22. Harnan SE, Pickering A, Pandor A, et al. Clinical decision rules for adults with minor head injury: a systematic review. J Trauma. 2011;71(1):245-251.
23. Stiell IG, Greenberg GH, McKnight RD, et al. A study to develop clinical decision rules for the use of radiography in acute ankle injuries. Ann Emerg Med. 1992;21(4):384-390.
24. Stiell IG, Greenberg GH, McKnight RD, et al. Decision rules for the use of radiography in acute ankle injuries: refinement and prospective validation. JAMA. 1993;269(9):1127-1132.
25. Stiell IG, Wells GA, Hoag RH, et al. Implementation of the Ottawa Knee Rule for the use of radiography in acute knee injuries. JAMA. 1997;278(23):2075-2079.
26. Stiell IG, Wells GA, Vandemheen K, et al. The Canadian CT Head Rule for patients with minor head injury. Lancet. 2001;357(9266):1391-1396.
27. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243-250.
28. Childs JD, Fritz JM, Flynn TW, et al. A clinical prediction rule to identify patients with low back pain most likely to benefit from spinal manipulation: a validation study. Ann Intern Med. 2004;141(12):920-928.
29. Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med. 1989;87(2):144-152.
30. Hebert JJ, Fritz JM. Clinical decision rules, spinal pain classification and prediction of treatment outcome: a discussion of recent reports in the rehabilitation literature. Chiropr Man Therap. 2012;20(1):19.
31. Riddle DL, Wells PS. Diagnosis of lowerextremity deep vein thrombosis in outpatients. Phys Ther. 2004;84(8):729-735.
32. Riddle DL, Hoppener MR, Kraaijenhagen RA, et al. Preliminary validation of clinical assessment for deep vein thrombosis in orthopaedic outpatients. Clin Orthop Relat Res. 2005;&NA;(432):252-257.
33. Newman DH, Schriger DL. Rethinking testing for pulmonary embolism: less is more. Ann Emerg Med. 2011;57(6):622-627, e3.
34. Wells PS, Owen C, Doucette S, et al. Does this patient have deep vein thrombosis? JAMA. 2006;295(2):199-207.
35. Dunkley EJ, Isbister GK, Sibbritt D, et al. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96(9):635-642.
36. Chatellier G, Zapletal E, Lemaitre D, et al. The number needed to treat: a clinically useful nomogram in its proper context. BMJ. 1996;312(7028):426-429.
37. Harrell FE Jr, Califf RM, Pryor DB, et al. Evaluating the yield of medical tests. JAMA. 1982;247(18):2543-2546.
38. Reid MC, Lane DA, Feinstein AR. Academic calculations versus clinical judgments: practicing physicians' use of quantitative measures of test accuracy. Am J Med. 1998;104(4):374-380.
39. Page J, Attia J. Using Bayes' nomogram to help interpret odds ratios. Evid Based Med. 2003;8:132-134.
40. Weihs KL, Houser TL, Batey SR, et al. Continuation phase treatment with bupropion SR effectively decreases the risk for relapse of depression. Biol Psychiatry. 2002;51(9):753-761.